Mark J. Enyedy - Jun 30, 2022 Form 4 Insider Report for ImmunoGen, Inc. (IMGN)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Renee Lentini, Attorney-in-Fact
Stock symbol
IMGN
Transactions as of
Jun 30, 2022
Transactions value $
$12,783
Form type
4
Date filed
7/5/2022, 04:28 PM
Previous filing
Jun 21, 2022
Next filing
Nov 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Award $12.8K +3.34K +0.77% $3.83* 436K Jun 30, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from January 1, 2022 through June 30, 2022
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2022